Biomerica (BMRA) Asset Writedowns and Impairment (2010 - 2026)
Biomerica (BMRA) posted Asset Writedowns and Impairment of -$143000.0 for Q1 2026, down 326.98% sequentially from $63000.0 in Q4 2025, and down 169.81% YoY from $204837.8 in Q1 2025.
Biomerica (BMRA) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Biomerica has reported Asset Writedowns and Impairment for 17 years, with the latest figure at -$143000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 169.81% year-over-year to -$143000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$20000.0 (up 71.01% YoY) and the FY2025 annual result came in at $8000.0, up 103.9% from the prior year.
- Asset Writedowns and Impairment slipped to -$143000.0 in Q1 2026 per BMRA's latest filing, from $63000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.1 million in Q1 2022 and troughed at -$954805.0 in Q2 2022.
- A 5-year average of -$18727.2 and a median of -$4000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment sank 607.89% in 2022, then soared 1675.0% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at $139000.0 in 2022, then slipped by 4.32% to $133000.0 in 2023, then sank by 103.01% to -$4000.0 in 2024, then jumped by 1675.0% to $63000.0 in 2025, then slumped by 326.98% to -$143000.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$143000.0, $63000.0, and $7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -143,000.00 |
| Feb 28, 2026 | -143,000.00 |
| Nov 30, 2025 | 63,000.00 |
| Nov 30, 2025 | 63,000.00 |
| Aug 31, 2025 | 7,000.00 |
| Aug 31, 2025 | 7,000.00 |
| May 31, 2025 | 53,000.00 |
| May 31, 2025 | 53,000.00 |
| Feb 28, 2025 | -53,000.00 |
| Feb 28, 2025 | -53,000.00 |
| Nov 30, 2024 | -4,000.00 |
| Nov 30, 2024 | -4,000.00 |
| Aug 31, 2024 | 12,000.00 |
| Aug 31, 2024 | 12,000.00 |
| May 31, 2024 | -24,000.00 |
| May 31, 2024 | -24,000.00 |
| Feb 29, 2024 | -174,000.00 |
| Feb 29, 2024 | -174,000.00 |
| Nov 30, 2023 | 133,000.00 |
| Nov 30, 2023 | 133,000.00 |